Cabaletta Bio (CABA) Assets Average (2019 - 2025)
Cabaletta Bio (CABA) recorded quarterly Assets Average of $177.4 million in Q4 2025, down 14.34% quarter-over-quarter from $207.1 million in Q3 2025, and down 8.89% on a YoY basis from $194.7 million in Q4 2024.
Cabaletta Bio (CABA) Assets Average (2019 - 2025) Analysis & Trends
Cabaletta Bio's Assets Average history runs 7 years deep, the most recent figure standing at $177.4 million for Q4 2025.
- In Q4 2025, Assets Average fell 8.89% year-over-year to $177.4 million; the TTM figure through Dec 2025 stood at $177.4 million (down 8.89% YoY), while the FY2025 annual figure was $175.1 million, down 20.19% from the prior year.
- Assets Average was $177.4 million for Q4 2025 at Cabaletta Bio, down from $207.1 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $247.1 million in Q1 2024 to a low of $96.8 million in Q3 2022.
- Historically, Assets Average has averaged $158.5 million across 5 years, with a median of $159.6 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Assets Average surged 124.17% in 2024, then retreated 29.13% in 2025.
- A 5-year view of Assets Average shows it stood at $124.5 million in 2021, then retreated by 16.2% to $104.3 million in 2022, then jumped by 104.63% to $213.5 million in 2023, then fell by 8.78% to $194.7 million in 2024, then declined by 8.89% to $177.4 million in 2025.
- The last three Assets Average figures came in at $177.4 million (Q4 2025), $207.1 million (Q3 2025), and $194.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - | 177.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 177.42 Mn |
| Sep 30, 2025 | 207.13 Mn |
| Jun 30, 2025 | 194.82 Mn |
| Mar 31, 2025 | 175.09 Mn |
| Dec 31, 2024 | 194.73 Mn |
| Sep 30, 2024 | 210.91 Mn |
| Jun 30, 2024 | 228.94 Mn |
| Mar 31, 2024 | 247.05 Mn |
| Dec 31, 2023 | 213.47 Mn |
| Sep 30, 2023 | 178.96 Mn |
| Jun 30, 2023 | 144.04 Mn |
| Mar 31, 2023 | 110.21 Mn |
| Dec 31, 2022 | 104.32 Mn |
| Sep 30, 2022 | 96.85 Mn |
| Jun 30, 2022 | 107.84 Mn |
| Mar 31, 2022 | 120.00 Mn |
| Dec 31, 2021 | 124.49 Mn |
| Sep 30, 2021 | 114.78 Mn |
| Jun 30, 2021 | 107.11 Mn |
| Mar 31, 2021 | 111.00 Mn |